Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Boston
Biotech
Novo taps Photys for multi-molecule cardiometabolic collab
Novo Nordisk will pay Photys up to $186 million to help develop proximity-based therapeutics for an unnamed cardiometabolic disease target.
Fraiser Kansteiner
Dec 18, 2024 7:30am
Eli Lilly opens $700M nucleic acid R&D center in Boston Seaport
Aug 13, 2024 9:32am
Novo Nordisk unveils new US hub as R&D investments soar
Feb 29, 2024 5:00am
Lab demand shrinks in life sciences real estate market
Sep 19, 2023 1:49pm
Novo Nordisk recruits, lays off staff in Boston expansion
Mar 2, 2023 9:25am
DM Clinical debuts new site, will begin Moderna trial enrollment
Jan 19, 2023 10:45am
